TACE inhibitors (BMS)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameTACE inhibitors (BMS)
Drug Alias NameTNFalpha converting enzyme inhibitors (Bristol-Myers Squibb)DPC-A37866DPH-067517DPC-A38088DPC-AF1737 +[7] 
ClassificationSmall molecules
Mechanisms of ActionDisintegrin and metalloproteinase domain-containing protein 17 inhibitors
TargetsDisintegrin and metalloproteinase domain-containing protein 17
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A